Asthma as a manifestation of post-COVID syndrome
https://doi.org/10.36604/1998-5029-2025-95-126-134
Abstract
Introduction. One of the most common complications of the novel coronavirus infection (COVID-19) involves respiratory system disorders, particularly bronchial obstruction.
Aim. To highlight the importance of vigilance regarding the onset of respiratory diseases, including asthma, in the post-COVID period.
Results. This article describes a clinical case of newly diagnosed severe asthma in a 35-year-old patient following COVID-19. A notable feature of the patient’s condition was prolonged eosinophilia. Sensitization to inhalant allergens was ruled out by a negative Phadiatop ImmunoCAP screening test. Despite receiving a fixed triple combination of an inhaled corticosteroid, a long-acting β2agonist, and a long-acting anticholinergic agent, the patient’s disease remained uncontrolled with persistent airway obstruction. A genetically engineered biological therapy was subsequently prescribed, resulting in a marked clinical improvement.
Conclusion. This clinical case illustrates a manifestation of post-COVID syndrome—new-onset asthma. Timely diagnosis enables the prompt selection of appropriate therapy, improving the patient’s quality of life and facilitating a return to normal daily activities.
About the Authors
I. V. Demko
Krasnoyarsk State Medical University; Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
Irina V. Demko, MD, PhD, DSc (Med.), Professor, Head of Department of Hospital Therapy and Immunology with Postgraduate Education Course; Head of Pulmonary Allergology Сenter
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
3 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
K. I. Chinyakova
Krasnoyarsk State Medical University; Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
Ksenia I. Chinyakova, MD, Postgraduate Student, Department of Hospital Therapy and Immunology with Postgraduate Education Course; Pulmonologist, Diagnostic and Treatment Department
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
3 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
A. Yu. Kraposhina
Krasnoyarsk State Medical University; Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
Angelina Yu. Kraposhina, MD, PhD (Med.), Associate Professor, Associate Professor of Department of Hospital Therapy and Immunology with a Postgraduate Education Course; Pulmonologist of Department of Pulmonology
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
3 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
E. A. Sobko
Krasnoyarsk State Medical University; Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
Elena A. Sobko, MD, PhD, DSc (Med.), Professor of the Department of Hospital Therapy and Immunology with a Postgraduate Course; Head of the Allergology Department
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
3 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
E. A. Bykhanova
Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Elena A. Bykhanova, MD, Resident of the Department of Hospital Therapy and Immunology with a Postgraduate Education Course
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
O. S. Kruglova
Krasnoyarsk State Medical University
Russian Federation
Russian Federation
Olga S. Kruglova, MD, Assistant of the Department of Hospital Therapy and Immunology with a Postgraduate Course
1 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
E. S. Mineeva
Krasnoyarsk Regional Clinical Hospital
Russian Federation
Russian Federation
Elena S. Mineeva, MD, Pulmonologist, Diagnostic and Treatment Department
3 Partizana Zheleznyaka Str., Krasnoyarsk, 660022
References
1. Bloom C.I. COVID-19 pandemic and asthma: what did we learn? Respirology 2023; 28(7):603–614. https://doi.org/10.1111/resp.14515
2. Han Q., Zheng B., Daines L., Sheikh A. Long-term sequelae of COVID-19: a systematic review and meta-analysis of one-year follow-up studies on post-COVID symptoms. Pathogens 2022; 11(2):269. https://doi.org/10.3390/pathogens11020269
3. Leshchenko I.V., Esaulova N.A., Glushkova T.V., Skornyakov S.N. [Respiratory disorders of post-COVID-19 syndrome]. Terapevticheskiy arkhiv 2023; 95(3):203–209 (in Russian). https://doi.org/10.26442/00403660.2023.03.202072
4. Atmar R.L., Guy E., Guntupalli K.K., Zimmerman J.L., Bandi V.D., Baxter B.D., Greenberg S.B. Respiratory tract viral infections in inner-city asthmatic adults. Arch. Intern. Med. 1998; 158(22):2453–2459. https://doi.org/10.1001/archinte.158.22.2453
5. Nenasheva N.M. [Virus-induced asthma: possible prevention and treatment]. Consilium Medicum 2016; 18(3):70–79 (in Russian). https://doi.org/10.26442/2075-1753_2016.3.70-79
6. Sigurs N., Gustafsson P.M., Bjarnason R., Lundberg F., Schmidt S., Sigurbergsson F., Kjellman B. Severe respiratory syncytial virus bronchiolitis in infancy and asthma and allergy at age 13. Am. J. Resp. Crit. Care Med. 2005; 171(2): 137– 141. https://doi.org/10.1164/rccm.200406-730oc
7. Kusel M.M., de Klerk N.H., Kebadze T., Vohma V., Holt P.G., Johnston S.L., Sly P.D. Early-life respiratory viral infections, atopic sensitization, and risk of subsequent development of persistent asthma. Allergy Clin. Immunol. 2007; 119(5):1105–1110. https://doi.org/10.1016/j.jaci.2006.12.669
8. Papadopoulos N.G., Xepapadaki P., Mallia P., Brusselle G., Watelet J.B., Xatzipsalti M., Foteinos G., van Drunen C.M., Fokkens W.J., D'Ambrosio C., Bonini S., Bossios A., Lötvall J., van Cauwenberge P., Holgate S.T., Canonica G.W., Szczeklik A., Rohde G., Kimpen J., Pitkäranta A., Mäkelä M., Chanez P., Ring J., Johnston S.L. Mechanisms of virus-induced asthma exacerbations: state-of-the-art. A GA2LEN and InterAirways document. Allergy 2007; 62(5):457–470. https://doi.org/10.1111/j.1398-9995.2007.01341.x
9. Busse W.W., Lemanske Jr.R.F., Gern J.E. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 2010; 376(9743):826–834. https://doi.org/10.1016/s0140-6736(10)61380-3
10. Martorano L.M., Grayson M.H. Respiratory viral infections and atopic development: from possible mechanisms to advances in treatment. Eur. J. Immunol. 2018; 48(3):407–414. https://doi.org/10.1002/eji.201747052
11. Rockx B., Kuiken T., Herfst S., Bestebroer T., Lamers M.M., Oude Munnink B.B., de Meulder D., van Amerongen G., van den Brand J., Okba N.M.A., Schipper D., van Run P., Leijten L., Sikkema R., Verschoor E., Verstrepen B., Bogers W., Langermans J., Drosten C., Fentener van Vlissingen M., Fouchier R., de Swart R., Koopmans M., Haagmans B.L. Comparative pathogenesis of COVID-19, MERS, and SARS in a nonhuman primate model. Science 2020; 368(6494):1012–1015. https://doi.org/10.1126/science.abb7314
12. Hosoki K., Chakraborty A., Sur S. Molecular mechanisms and epidemiology of COVID-19 from an allergist's perspective. J. Allergy Clin. Immunol. 2020; 146(2):285–299. https://doi.org/10.1016/j.jaci.2020.05.033
13. Leshchenko I.V., Esaulova N.A. [Post-covid bronchoobstructive syndrome in practice of general practitioner and pulmonologist: largescale study]. Pul'monologiya = Russian Pulmonology 2022; 32(4):539–547 (in Russian). https://doi.org/10.18093/0869-0189-2022-32-4-539-547
Review
For citations:
Demko I.V., Chinyakova K.I., Kraposhina A.Yu., Sobko E.A., Bykhanova E.A., Kruglova O.S., Mineeva E.S. Asthma as a manifestation of post-COVID syndrome. Bulletin Physiology and Pathology of Respiration. 2025;(95):126-134. (In Russ.) https://doi.org/10.36604/1998-5029-2025-95-126-134
Views:
137
Email this article 